Systematic studies of the cancer genome are providing unprecedented insights into the molecular nature of human cancer. Using this information to guide the development and application of therapies in
Pvclust result for GI50 measures in the CGP tumor cells; Table B. Cluster results for EN genes; Table C. GSEA results for minimal EN models of PD_0325901; Table D. GSEA results for the minimal EN gene
Tamoxifen (TAM), a selective oestrogen receptor modulator, is one of the most used treatments in oestrogen receptor-positive (ER+) early and metastatic breast cancer (BC) patients. The response to TAM
gCSI 2019 PharmacoSet (PSet) generated by ORCESTRA. Metadata can be found on ORCESTRA at: http://orcestra.ca/10.5281/zenodo.4737437. An unfiltered version of the gCSI dataset, updated since the public
Additional file 14. Supplementary Table S12. Top 20 GO Biological Processes enrichment of elastic-net derived genes for PTX analysis without blood cancers. P-values shown are uncorrected for multiple